WRTC Share Price | Wrap Technologies, Inc. Stock Analysis & Recommendation

Q: What does Wrap Technologies, Inc. do?

Overview:Wrap Technologies, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot:Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) Market-cap: USD 82.44 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -2.18 Return on Equity: -596.22% Price to Book: 32.12Contact Details:Registrar Address: Not available.

Q: Should I buy, sell or hold Wrap Technologies, Inc.?

Based on the current situation of Wrap Technologies, Inc., it would be advisable to consider selling your shares. The company is facing several challenges, including poor management efficiency reflected in a low return on equity (ROE) of 0%, which indicates that it has not been able to generate profits effectively. Additionally, the recent financial results show a significant decline in net sales, with a drop of 21.07%, and the inventory turnover ratio is at its lowest point, suggesting inefficiencies in managing stock.Furthermore, Wrap Technologies is operating with negative EBITDA, which adds to the risk associated with the stock. The lack of positive returns over the past year, despite a rise in profits, raises concerns about its overall financial health. Lastly, the decrease in institutional investor participation indicates a lack of confidence from more knowledgeable investors, as they have reduced their stakes in the company.Considering these factors, it may be prudent to sell your shares in Wrap Technologies, Inc. and reassess your investment strategy.

Q: Is Wrap Technologies, Inc. technically bullish or bearish?

As of 11 September 2025, the technical trend for Wrap Technologies, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators influencing the outlook. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Bollinger Bands are bullish for both weekly and monthly periods. However, the daily moving averages are mildly bearish, and the KST shows a bearish monthly signal. The Dow Theory indicates a mildly bullish stance on both weekly and monthly timeframes, and the OBV is mildly bullish as well.In terms of performance, Wrap Technologies has outperformed the S&P 500 over the past week and month, with returns of 12.57% and 53.57% respectively, while the S&P 500 returned 1.05% and 2.33%. However, over longer periods, such as the 3-year and 5-year marks, the stock has significantly underperformed compared to the benchmark.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

319.97 k

Shareholding (Sep 2025)

FII

1.43%

Held by 14 FIIs

DII

94.14%

Held by 5 DIIs

Promoter

0.08%

How big is Wrap Technologies, Inc.?

22-Jun-2025

As of Jun 18, Wrap Technologies, Inc. has a market capitalization of 82.44 million and reported net sales of 3.79 million with a net profit of -5.89 million over the latest four quarters. Shareholder's funds are at 0.25 million, and total assets are 15.58 million as of Dec 24.

View full answer

What does Wrap Technologies, Inc. do?

22-Jun-2025

Wrap Technologies, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a market cap of $82.44 million as of March 2025, with no net profit and negative key financial metrics.

View full answer

Should I buy, sell or hold Wrap Technologies, Inc.?

22-Jun-2025

Is Wrap Technologies, Inc. technically bullish or bearish?

20-Sep-2025

As of September 11, 2025, Wrap Technologies, Inc. has a neutral technical outlook with mixed indicators, showing a shift from mildly bearish to sideways, while outperforming the S&P 500 in the short term but underperforming over the long term.

View full answer

Compare Wrap Technologies, Inc. with Similar Stocks

Milestone Scientific, Inc.Prenetics Global Ltd.CollPlant Biotechnologies Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

With a growth in Net Sales of 151.43%, the company declared Very Positive results in Sep 25

Risky -

Increasing Participation by Institutional Investors

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 87 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.40

Return on Equity

-100.53%

Price to Book

6.13

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Sep 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-33.03%

6 Months

-32.09%

1 Year

-33.49%

2 Years

-48.59%

3 Years

-16.57%

4 Years

-41.83%

5 Years

-73.69%

Wrap Technologies, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.24%

EBIT Growth (5y)

-4.53%

EBIT to Interest (avg)

-18.23

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-2.18

Sales to Capital Employed (avg)

1.23

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

14.14%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.13

EV to EBIT

-5.72

EV to EBITDA

-6.02

EV to Capital Employed

9.57

EV to Sales

19.60

PEG Ratio

Dividend Yield

ROCE (Latest)

-167.40%

ROE (Latest)

-100.53%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 5 Schemes (4.35%)

Foreign Institutions

Held by 14 Foreign Institutions (1.43%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 150.00% vs -83.33% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -240.00% vs 166.67% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.50",
          "val2": "0.60",
          "chgp": "150.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.60",
          "val2": "-3.40",
          "chgp": "23.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "5.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.80",
          "val2": "2.00",
          "chgp": "-240.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,851.80%",
          "val2": "-6,114.70%",
          "chgp": "426.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -26.23% vs -23.75% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 80.46% vs -71.59% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.50",
          "val2": "6.10",
          "chgp": "-26.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-14.40",
          "val2": "-17.80",
          "chgp": "19.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.60",
          "val2": "-12.00",
          "chgp": "180.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.90",
          "val2": "-30.20",
          "chgp": "80.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,454.00%",
          "val2": "-3,052.70%",
          "chgp": "-40.13%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

1.50

0.60

150.00%

Operating Profit (PBDIT) excl Other Income

-2.60

-3.40

23.53%

Interest

0.00

Exceptional Items

0.00

5.60

-100.00%

Consolidate Net Profit

-2.80

2.00

-240.00%

Operating Profit Margin (Excl OI)

-1,851.80%

-6,114.70%

426.29%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 150.00% vs -83.33% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -240.00% vs 166.67% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

4.50

6.10

-26.23%

Operating Profit (PBDIT) excl Other Income

-14.40

-17.80

19.10%

Interest

0.00

Exceptional Items

9.60

-12.00

180.00%

Consolidate Net Profit

-5.90

-30.20

80.46%

Operating Profit Margin (Excl OI)

-3,454.00%

-3,052.70%

-40.13%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -26.23% vs -23.75% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 80.46% vs -71.59% in Dec 2023

All Annual Results

Company CV

About Wrap Technologies, Inc.

Wrap Technologies, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available